» Articles » PMID: 34282109

Risk Prediction Model Based on Biomarkers of Remodeling in Patients with Acute Anterior ST-Segment Elevation Myocardial Infarction

Overview
Journal Med Sci Monit
Date 2021 Jul 20
PMID 34282109
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND The aim of the present study was to develop a risk prediction model in patients with acute anterior ST-segment elevation myocardial infarction (STEMI). MATERIAL AND METHODS Clinical data from 333 patients with acute anterior STEMI were retrospectively analyzed. Clinical echocardiographic and angiographic data from patients with left ventricular remodeling (LVR) and those without LVR were compared. Factors that influenced risk were identified using multivariate logistic regression analysis. The area under the curve (AUC) of the receiver operating characteristic curve was used to assess the diagnostic performance of the model. RESULTS After 6-month follow-up, 135 of the patients experienced LVR (LVR group), whereas 198 did not (non-LVR group). Results of multivariate analysis showed that the number of stenosed coronary vessels, left ventricular end-diastolic volume (LVEDV), left ventricular ejection fraction (LVEF), transforming growth factor-beta (TGF-ß) at admission, and cardiac troponin I 3 days after admission (3-d cTnI) were all factors predictive of LVR in patients with acute anterior STEMI (all P<0.05). The established prediction model was Y=-20.639+0.711×number of stenosed coronary vessels + 0.137×LVEDV-0.129×LVEF+0.026×TGF-ß at admission + 0.162×3-d cTnI. The estimated AUC of this model was 0.978 (95% confidence interval [CI] 0.955-0.991), significantly superior to the single-factor numbers for stenosed coronary vessel of 0.650 (95% CI 0.597-0.702), LVEDV of 0.876 (95% CI 0.836-0.910), LVEF of 0.684 (95% CI 0.631-0.734), TGF-ß at admission of 0.696 (95% CI 0.644-0.745), cTnI at admission of 0.913 (95% CI 0.877-0.941), and 3-d cTnI of 0.945 (95% CI 0.914-0.967). CONCLUSIONS The established model had excellent diagnostic accuracy for predicting LVR in patients with acute anterior STEMI.

Citing Articles

Vitamin C Regulates the Profibrotic Activity of Fibroblasts in In Vitro Replica Settings of Myocardial Infarction.

Xu Y, Zheng H, Nilcham P, Bucur O, Vogt F, Slabu I Int J Mol Sci. 2023; 24(9).

PMID: 37176085 PMC: 10179686. DOI: 10.3390/ijms24098379.


Development and validation of a predictive model for adverse left ventricular remodeling in NSTEMI patients after primary percutaneous coronary intervention.

Wang L, Liu T, Wang C, Xuan H, Xu X, Yin J BMC Cardiovasc Disord. 2022; 22(1):386.

PMID: 36030211 PMC: 9420298. DOI: 10.1186/s12872-022-02831-2.


Characteristics of the Cardiosplenic Axis in Patients with Fatal Myocardial Infarction.

Kercheva M, Ryabov V, Trusov A, Stepanov I, Kzhyshkowska J Life (Basel). 2022; 12(5).

PMID: 35629341 PMC: 9147017. DOI: 10.3390/life12050673.

References
1.
Pedersen F, Butrymovich V, Kelbaek H, Wachtell K, Helqvist S, Kastrup J . Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014; 64(20):2101-8. DOI: 10.1016/j.jacc.2014.08.037. View

2.
Khera S, Kolte D, Gupta T, Subramanian K, Khanna N, Aronow W . Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. J Am Coll Cardiol. 2015; 66(18):1961-1972. DOI: 10.1016/j.jacc.2015.08.865. View

3.
Yao Y, Hu C, Song Q, Li Y, Da X, Yu Y . ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart. Cardiovasc Res. 2019; 116(5):956-969. PMC: 7868664. DOI: 10.1093/cvr/cvz187. View

4.
Zhu R, Sun H, Yu K, Zhong Y, Shi H, Wei Y . Interleukin-37 and Dendritic Cells Treated With Interleukin-37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction. J Am Heart Assoc. 2016; 5(12). PMC: 5210436. DOI: 10.1161/JAHA.116.004406. View

5.
Pfeffer M, Braunwald E . Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990; 81(4):1161-72. DOI: 10.1161/01.cir.81.4.1161. View